This report examines the immune response patterns in blood and urine of individuals hospitalized during the early COVID-19 pandemic, focusing on those with confirmed nicotine exposure.
Understanding these immune signatures can help inform public health strategies and improve management of COVID-19 among smokers and nicotine users.